Xilio Therapeutics, Inc.

XLO • NASDAQ • Stock Fundamentals

Xilio Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rene Russo, with a market cap of $50.0M.

Market Cap$50.0M

Employees73.0

CEORene Russo

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. (XLO) has a market capitalization of $50.0M and trades on NASDAQ.

Xilio Therapeutics, Inc. has approximately 73 employees.